- Subjects will be evaluated for long term safety and occurrence of adverse events according to the requirements established by the POB gene therapy parent protocol, the FDA guidance and the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), to include: